![Kevin Taylor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Taylor
Direttore operativo presso Galvanize Therapeutics, Inc.
Profilo
Kevin Taylor is currently the Chief Operating Officer at Galvanize Therapeutics, Inc. Prior to this, he worked as the Director of Process & Product Development at Acclarent, Inc., Principal at Atrionix, Inc., and Vice President of Development & Operations at ReCor Medical, Inc. He received his undergraduate degree from Drexel University and his MBA from The University of Chicago Booth School of Business.
Posizioni attive di Kevin Taylor
Società | Posizione | Inizio |
---|---|---|
Galvanize Therapeutics, Inc.
![]() Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Direttore operativo | - |
Precedenti posizioni note di Kevin Taylor
Società | Posizione | Fine |
---|---|---|
Acclarent, Inc.
![]() Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
Atrionix, Inc.
![]() Atrionix, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million. | Corporate Officer/Principal | - |
ReCor Medical, Inc.
![]() ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Direttore operativo | - |
Formazione di Kevin Taylor
Drexel University | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Acclarent, Inc.
![]() Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Health Technology |
Atrionix, Inc.
![]() Atrionix, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million. | Health Technology |
ReCor Medical, Inc.
![]() ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Health Technology |
Galvanize Therapeutics, Inc.
![]() Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Commercial Services |
- Borsa valori
- Insiders
- Kevin Taylor